[go: up one dir, main page]

DE602004027800D1 - Zusammensetzung zur ophthalmischen verwendung - Google Patents

Zusammensetzung zur ophthalmischen verwendung

Info

Publication number
DE602004027800D1
DE602004027800D1 DE602004027800T DE602004027800T DE602004027800D1 DE 602004027800 D1 DE602004027800 D1 DE 602004027800D1 DE 602004027800 T DE602004027800 T DE 602004027800T DE 602004027800 T DE602004027800 T DE 602004027800T DE 602004027800 D1 DE602004027800 D1 DE 602004027800D1
Authority
DE
Germany
Prior art keywords
ophthalmic solution
hydroxypropylmethylcellulose
molecular weight
present
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004027800T
Other languages
English (en)
Inventor
Akira Tsuzuki
Sayuri Iwamuro
Sadayasu Tanikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menicon Co Ltd
Original Assignee
Menicon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menicon Co Ltd filed Critical Menicon Co Ltd
Publication of DE602004027800D1 publication Critical patent/DE602004027800D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
DE602004027800T 2003-05-15 2004-04-30 Zusammensetzung zur ophthalmischen verwendung Expired - Lifetime DE602004027800D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003137828 2003-05-15
PCT/JP2004/005837 WO2004100993A1 (ja) 2003-05-15 2004-04-30 眼科用組成物

Publications (1)

Publication Number Publication Date
DE602004027800D1 true DE602004027800D1 (de) 2010-08-05

Family

ID=33447269

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027800T Expired - Lifetime DE602004027800D1 (de) 2003-05-15 2004-04-30 Zusammensetzung zur ophthalmischen verwendung

Country Status (6)

Country Link
US (1) US20060052340A1 (de)
EP (1) EP1623722B1 (de)
JP (1) JP4739022B2 (de)
AT (1) ATE471723T1 (de)
DE (1) DE602004027800D1 (de)
WO (1) WO2004100993A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008152705A1 (ja) * 2007-06-13 2008-12-18 Menicon Co., Ltd. コンタクトレンズ用洗浄シート
JP2009096790A (ja) * 2007-09-28 2009-05-07 Rohto Pharmaceut Co Ltd 疲れ目改善用及び／又はかすみ目改善用コンタクトレンズ装着液
CA3014633C (en) 2007-10-08 2022-05-17 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
EP3246048B1 (de) * 2009-02-18 2024-04-03 Calm Water Therapeutics LLC Verwendung von bifunktionellem copolymer für augenärztliche anwendungen
CA2764635C (en) * 2009-06-09 2018-05-22 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
WO2011022736A1 (en) * 2009-08-21 2011-02-24 Belkin International, Inc. Entertainment control system and related methods
WO2011057275A2 (en) * 2009-11-09 2011-05-12 Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University Molecular films for hydrophobic implant surfaces
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP2011207847A (ja) * 2010-03-30 2011-10-20 Nitto Denko Corp フィルム状製剤及びその製造方法
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5587359B2 (ja) * 2012-03-12 2014-09-10 株式会社メニコン コンタクトレンズ用組成物
AU2013347897A1 (en) 2012-11-21 2015-07-09 University Of Louisville Research Foundation, Inc Compositions and methods for reducing oxidative damage
JP5731046B1 (ja) * 2014-05-30 2015-06-10 株式会社メニコン コンタクトレンズ用組成物
JP6530769B2 (ja) * 2015-01-21 2019-06-12 クオリカプス株式会社 インク及びこれを用いた可食体の製造方法並びに可食体の印刷方法
WO2016130478A1 (en) 2015-02-09 2016-08-18 University Of Louisville Research Foundation, Inc. Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
WO2018009177A1 (en) 2016-07-06 2018-01-11 Eyeon Particle Sciences Llc Bi-functional co-polymer use for ophthalmic and other topical and local applications
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
JP4167463B2 (ja) * 1997-05-14 2008-10-15 千寿製薬株式会社 再分散性の良い水性懸濁液剤
WO1999016447A1 (fr) * 1997-09-26 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse contenant un agent antiviral a ossature purine ou pyrimidine
JP4848575B2 (ja) * 2000-03-30 2011-12-28 ゼリア新薬工業株式会社 アラントインを配合した安定な液剤
JP2001318348A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ装着液
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
JP4099624B2 (ja) * 2001-04-24 2008-06-11 ライオン株式会社 ソフトコンタクトレンズ用組成物
JP2003183157A (ja) * 2001-12-19 2003-07-03 Lion Corp 眼科用組成物

Also Published As

Publication number Publication date
US20060052340A1 (en) 2006-03-09
EP1623722B1 (de) 2010-06-23
ATE471723T1 (de) 2010-07-15
EP1623722A1 (de) 2006-02-08
EP1623722A4 (de) 2007-03-14
JPWO2004100993A1 (ja) 2006-07-13
JP4739022B2 (ja) 2011-08-03
WO2004100993A1 (ja) 2004-11-25

Similar Documents

Publication Publication Date Title
ATE471723T1 (de) Zusammensetzung zur ophthalmischen verwendung
MX2009006106A (es) Anteojos con dispositivo de barrera para vapor.
MX2010003774A (es) Formulaciones oftalmicas acuosas.
EA201100393A1 (ru) Применение усиливающих агентов, возможно связанных с рибофлавином, а также соответствующих офтальмологических композиций для перекрестного сшивания роговицы при лечении кератоконуса или других эктазийных расстройств роговицы
WO2005002520A3 (en) Ophthalmic compositions for treating ocular hypertension
WO2007103349A3 (en) Devices, methods and compositions for presbyopia correction using ultrashort pulse lasers
WO2008012367A3 (en) Compositions containing quaternary ammonium compounds
BR0211935A (pt) Métodos para o desenho de lentes oftálmicas multifocais
BRPI0518289A2 (pt) mÉtodos e composiÇÕes para o tratamento de desordens oculares
CL2013002467A1 (es) Composición oftálmica que comprende al menos 0,67% pero no más de 1,0% p/v de olopatadina disuelta en solucion, peg con un peso molecular de 300 a 500, polivinilpirrolidona, hidroxialquil ß-ciclodextrina, hidroxialquil ?-ciclodextrina o su combinación y cloruro de benzalconio; gotario que comprende a la composición oftálmica; y su uso en el tratamiento de la conjuntivitis alérgica ocular.
MY145881A (en) Method for designing spectacle lenses taking into account an individual's head and eye movement
CY1106476T1 (el) Υποκατεστημενες διυδροκιναζολινες με αντι-ιικες ιδιοτητες
MY153979A (en) Substituted piperidino-dihydrothienopyrimidine
SG157231A1 (en) Substituted p-diaminobenzene derivatives
ATE547107T1 (de) Verwendung von selenhefe in der behandlung von alzheimers krankheit
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
BR0307627A (pt) Métodos e composições para o tratamento de doenças do olho
WO2005004814A3 (en) Sirt1 and genetic disorders
TW200505865A (en) Compounds useful for the treatment of diseases
ATE525114T1 (de) Kosmetikprodukt enthaltend ein bestandteil aus salmonidae-eierstockmembrane
WO2005020917A3 (en) Ophthalmic compositions for treating ocular hypertension
ATE411296T1 (de) Imidazolinderivate mit cb1-antagonistischer wirkung
ATE423989T1 (de) Progressive brillenlinse
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις